Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Seattle Genetics the Perfect Stock?
Motley Fool
Friday, July 15, 2011 - 12:59am
tags:
Seattle Genetics
Merck Job Cuts To Pick Up Steam
Pharmalot
Thursday, July 14, 2011 - 1:30pm
tags:
Merck, layoffs
Seattle Genetics: Adcetris Panel Reconvenes (live blog)
TheStreet.com
Thursday, July 14, 2011 - 1:28pm
tags:
Seattle Genetics, advisory panels, Adcetris, FDA, anaplastic large-cell lymphoma
Boehringer Must Pay Overtime To Sales Rep: Judge
Pharmalot
Thursday, July 14, 2011 - 1:05pm
tags:
overtime lawsuits, Boehringer Ingelheim, drug reps
Earnings Preview: Eli Lilly
Yahoo/Zacks.com
Thursday, July 14, 2011 - 1:04pm
tags:
earnings, Eli Lilly
Medicis Tumbles Most in Two Months After Woman Is Found Dead in CEO’s Home
Bloomberg
Thursday, July 14, 2011 - 12:32pm
tags:
Pharma CEOs, Medicis, Jonah Shacknai
Daily Dose of Gilead Drugs Prevent Heterosexual HIV Infection, Study Shows
Bloomberg
Thursday, July 14, 2011 - 12:20pm
tags:
HIV, Gilead Sciences
Jazz Pharmaceuticals hops 6% on analyst rating
Marketwatch
Thursday, July 14, 2011 - 12:17pm
tags:
Jazz Pharmaceuticals
Cephalon shareholders okay Teva takeover
Marketwatch
Thursday, July 14, 2011 - 12:15pm
tags:
Teva Pharmaceuticals, shareholders, M&A, Cephalon
Earnings Preview: Abbott Labs
Yahoo/Zacks.com
Thursday, July 14, 2011 - 12:12pm
tags:
earnings, Abbott Laboratories
J&J unit closes deal for Russian OTC brands
Yahoo
Thursday, July 14, 2011 - 11:53am
tags:
OTC, Russia, JNJ, Cilag GmbH
Human Genome Sciences and Glaxo say EU regulators approved their lupus drug Benlysta
Yahoo/AP
Thursday, July 14, 2011 - 11:45am
tags:
Human Genome Sciences, GSK, Europe, lupus, Benlysta
Docs Like Their iPADS, But They Like Reps, Too
Pharmalot
Thursday, July 14, 2011 - 11:41am
tags:
iPad, physicians, drug reps
Earnings Preview: Forest Labs
Yahoo/Zacks.com
Wednesday, July 13, 2011 - 6:26pm
tags:
earnings, Forest Labs
Phase III Data Mixed on Sanofi's Lemtrada
Yahoo/Zacks.com
Wednesday, July 13, 2011 - 6:25pm
tags:
Sanofi, Lemtrada, MS, multiple sclerosis, alemtuzumab
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wednesday, July 13, 2011 - 4:53pm
tags:
MannKind, Celgene, Amarin, Vertex Pharmaceuticals, BioSante, Keryx, Amylin, Regeneron, Immunogen, Cubist Pharmaceuticals, Isis Pharmaceuticals, Sunesis, OPKO Health, SciClone, Cephalon
No Post-IPO Blues for Endocyte
Seeking Alpha
Wednesday, July 13, 2011 - 4:50pm
tags:
IPOs, Endocyte, ovarian cancer, EC145, small molecule drugs
Earnings Preview: Johnson & Johnson
Yahoo/Zacks.com
Wednesday, July 13, 2011 - 4:48pm
tags:
JNJ, earnings
Merck chief concerned over future U.S. biopharma innovation
Fierce Biotech
Wednesday, July 13, 2011 - 12:06pm
tags:
Merck, Kenneth Frazier, Pharma CEOs, innovation
Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN Pharmaceuticals
Marketwatch
Wednesday, July 13, 2011 - 11:55am
tags:
Array Biopharma, ARRY-543, Aslan, HER2 Inhibitor, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.